• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/9/21 9:13:19 AM ET
    $MGLN
    Hospital/Nursing Management
    Health Care
    Get the next $MGLN alert in real time by email
    SC 13G 1 magellanhealth13g_123120.htm

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    ( Amendment No. )*

    Magellan Health Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    559079207

    (CUSIP Number) 

    December 31, 2020

    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    x  Rule 13d-1(b)
    ¨  Rule 13d-1(c)
    ¨  Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     
     

     

             
    CUSIP No. 559079207   13G   Page 2 of 4 Pages
             

     

             
    1.  

    NAMES OF REPORTING PERSONS

     

    Victory Capital Management Inc.


    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

    13-2700161

       
    2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    ¨
    (b)    ¨
       
    3.   SEC USE ONLY
     
       
    4.   CITIZENSHIP OR PLACE OF ORGANIZATION
     
    New York
       

     

             
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5.  

    SOLE VOTING POWER
     
    1,349,797

      6.   SHARED VOTING POWER
     
    0
      7.   SOLE DISPOSITIVE POWER
     
    1,372,770
      8.   SHARED DISPOSITIVE POWER
     
    0

     

             
    9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,372,770
       
    10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ¨
       
    11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.36%
       
    12.   TYPE OF REPORTING PERSON (see instructions)

    IA
       
             
             
                     
     
     

     

             
    CUSIP No. 559079207   13G   Page 3 of 4 Pages
             

    Item 1.

      (a) Name of Issuer
    Magellan Health Inc.
         
      (b)

    Address of Issuer’s Principal Executive Offices

    4801 E. Washington St

    Phoenix, AZ 85034

         

    Item 2.

      (a) Name of Persons Filing
    Victory Capital Management Inc.
         
      (b)

    Address of the Principal Office or, if none, residence
    4900 Tiedeman Rd. 4th Floor

    Brooklyn, OH 44144

         
      (c) Citizenship
    New York
         
      (d) Title of Class of Securities
    Common Stock
         
      (e) CUSIP Number
    559079207
         

    Item 3.  If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
           
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) x An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
           
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
           
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
           
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(J).
           

    Item 4.  Ownership.

     
     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

             
      (a)   Amount beneficially owned:  1,372,770
             
      (b)   Percent of class:  5.36%
             
      (c)   Number of shares as to which the person has:
             
          (i)

    Sole power to vote or to direct the vote:  1,349,797

             
          (ii) Shared power to vote or to direct the vote:  0
             
          (iii) Sole power to dispose or to direct the disposition of:  1,372,770
             
          (iv)

    Shared power to dispose or to direct the disposition of:  0

    Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

             

    Item 5.  Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ¨

    Item 6.  Ownership of More than Five Percent on Behalf of Another Person.

    The clients of Victory Capital Management Inc., including investment companies registered under the Investment Company Act of 1940 and separately managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the class of securities reported herein. No client has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5% of such class.

     

    Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     Not applicable

    Item 8.  Identification and Classification of Members of the Group.

     Not applicable.

    Item 9.  Notice of Dissolution of Group.

     Not applicable.

    Item 10.  Certification.

           
      (a)   The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):
             
          By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.  
             
             
     
     

     

             
    CUSIP No. 559079207   13G   Page 4 of 4 Pages
             

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    2/9/2021

    Date

     

    /s/ Colin S. Kinney

    Signature

     

    Colin S. Kinney / Chief Compliance Officer

    Name/Title

     

     

    Get the next $MGLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MGLN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MGLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Journey Venture Studio Appoints First Four Board Members

    Notable Seasoned Entrepreneurs Will Support Inaugural Founders-In-Residence Cohort and the Development of Future Disruptive Healthcare Startups in Phoenix PHOENIX, July 24, 2023 /PRNewswire-PRWeb/ -- The Journey Venture Studio announced today the appointment of the first four members to its board of directors. Each board member was sought out as a mission-aligned partner as the studio prepares to launch its first Founder in Residence Cohort. The first four board members include: Heidi Jannenga, WebPT Co-founder & Chief Clinical Officer Jason Wood, Managing Director with Morgan Stanley Investment Management's Next Level Fund Andy Lombard, CEO of Arizona Venture Development Corporation (AVC) J

    7/24/23 9:00:00 AM ET
    $CNC
    $MGLN
    Medical Specialities
    Health Care
    Hospital/Nursing Management

    Concerned Shareholders of Cano Health Nominate Highly Qualified, Independent Director Candidates and Propose Removal of Dr. Marlow Hernandez from Board for Cause

    Group Details the Case for Urgent Change at Cano Following an Extended Period of Underperformance, Failed Capital Allocation, and Extremely Poor Governance and Strategic Execution Urges Stockholders to WITHHOLD Support for Incumbent Directors as Parties Await a Resolution of Litigation to Compel Company to Reopen Window for Nominating Director Candidates and Making Proposals Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group," "us" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("Cano" or the "Company") (NYSE:CANO), today announced that they have submitted a notice to the

    5/18/23 9:28:00 AM ET
    $BKD
    $CANO
    $CIVI
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services
    Oil & Gas Production

    Magellan Health Opens 24-hour Crisis Line for Individuals Impacted by Hurricane Ian

    Consultation and resources available at no cost to local community Magellan Health, Inc. today announced that it has opened a complimentary 24-hour crisis line for individuals impacted by the aftermath of Hurricane Ian. The toll-free number to access free, confidential consultation services is 1-800-327-7451. Magellan confidential consultation services are offered at no charge to the community to assist individuals as they work to cope with the feelings of fear, sadness, anger, or hopelessness related to these kinds of natural disasters. Crisis line callers may also seek information and guidance to other available resources, such as community-based support. Tip sheets with resources spe

    9/29/22 11:00:00 AM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    $MGLN
    SEC Filings

    View All

    SEC Form 15-12B filed by Magellan Health, Inc.

    15-12B - MAGELLAN HEALTH INC (0000019411) (Filer)

    1/14/22 4:08:42 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    SEC Form S-8 POS filed by Magellan Health, Inc.

    S-8 POS - MAGELLAN HEALTH INC (0000019411) (Filer)

    1/4/22 4:54:57 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    SEC Form S-8 POS filed by Magellan Health, Inc.

    S-8 POS - MAGELLAN HEALTH INC (0000019411) (Filer)

    1/4/22 4:52:36 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    $MGLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Feld Peter A returned 2,374,798 units of Ordinary Common Stock to the company, closing all direct ownership in the company

    4 - MAGELLAN HEALTH INC (0000019411) (Issuer)

    1/4/22 5:43:07 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    SEC Form 4: Shulman Steven J returned 27,451 units of Ordinary Common Stock to the company, closing all direct ownership in the company

    4 - MAGELLAN HEALTH INC (0000019411) (Issuer)

    1/4/22 5:22:13 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    SEC Form 4: West Jeffrey N returned 25,692 units of Ordinary Common Stock to the company, closing all direct ownership in the company

    4 - MAGELLAN HEALTH INC (0000019411) (Issuer)

    1/4/22 5:23:35 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    $MGLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Magellan Health, Inc. (Amendment)

    SC 13D/A - MAGELLAN HEALTH INC (0000019411) (Subject)

    1/6/22 5:18:35 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Magellan Health, Inc.

    SC 13G - MAGELLAN HEALTH INC (0000019411) (Subject)

    7/6/21 2:59:29 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13D/A filed by Magellan Health, Inc. (Amendment)

    SC 13D/A - MAGELLAN HEALTH INC (0000019411) (Subject)

    4/27/21 3:59:03 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    $MGLN
    Financials

    Live finance-specific insights

    View All

    Magellan Health Reports Third Quarter 2021 Financial Results

    Magellan Health, Inc. (NASDAQ:MGLN) today announced financial results for the third quarter ended September 30, 2021, as summarized below:             Three Months Ended   Nine Months Ended Sept 30   Sept 30 (In millions, except per share amounts)           Continuing Operations     2021         2020     Chg     2021     2020   Chg Net revenue $   1,254.1     $   1,170.1     7.2 %   $ 3,636.5   $ 3,392.6   7.2 % Net (loss) income $   (0.1 )   $   (17.3 )   NM     $ 21.9   $ 28.7   -23.7 % Segment profit [1] $   38.

    11/5/21 6:30:00 AM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    Magellan Health Reports Second Quarter 2021 Financial Results

    Magellan Health, Inc. (NASDAQ:MGLN) today announced financial results for the second quarter ended June 30, 2021, as summarized below: Three Months Ended     Six Months Ended June 30     June 30 (In millions, except per share amounts)                         Continuing Operations     2021         2020   Chg         2021       2020   Chg Net revenue $   1,220.8     $   1,100.1   11.0 %   $   2,382.4   $   2,222.5   7.2 % Net income (loss) $   (6.5 )   $   47.1   -113.7 %   $   22.0   $   46.0   -52.1 % Segment profit [1]

    8/5/21 6:30:00 AM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    Magellan Health Reports 2020 Financial Results

    PHOENIX--(BUSINESS WIRE)--Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the fourth quarter and the year ended December 31, 2020, as summarized below:   Three Months Ended Twelve Months Ended December 31 December 31 (In millions, except per share amounts) Continuing Operations 2020 2019 Chg 2020 2019 Chg Net revenue $ 1,185.0   $ 1,133.8 4.5 % $ 4,577.5 $ 4,565.6 0.3 % Net (loss) income $ (24.7 ) $ 9.5 NM   $ 4.0 $ 12.6 -67.9 % Segment profit [1] $ 11.3   $ 55.9 -79.8 % $ 14

    2/26/21 4:55:00 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    $MGLN
    Leadership Updates

    Live Leadership Updates

    View All

    The Journey Venture Studio Appoints First Four Board Members

    Notable Seasoned Entrepreneurs Will Support Inaugural Founders-In-Residence Cohort and the Development of Future Disruptive Healthcare Startups in Phoenix PHOENIX, July 24, 2023 /PRNewswire-PRWeb/ -- The Journey Venture Studio announced today the appointment of the first four members to its board of directors. Each board member was sought out as a mission-aligned partner as the studio prepares to launch its first Founder in Residence Cohort. The first four board members include: Heidi Jannenga, WebPT Co-founder & Chief Clinical Officer Jason Wood, Managing Director with Morgan Stanley Investment Management's Next Level Fund Andy Lombard, CEO of Arizona Venture Development Corporation (AVC) J

    7/24/23 9:00:00 AM ET
    $CNC
    $MGLN
    Medical Specialities
    Health Care
    Hospital/Nursing Management

    Magellan Health Appoints Tom Britt as Chief Information Officer

    Magellan Health, Inc. today announced it has appointed Tom Britt as chief information officer for Magellan Health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220808005111/en/Tom Britt (Photo: Business Wire) Britt will work closely with Magellan's executive leadership to create, develop and implement information technology strategy and digital solutions while leveraging best practices and delivering data-enhanced products and services through innovative technology platforms. "Tom is a strong leader with over 25 years of significant leadership experience in building innovative digital products and solutions while leading high

    8/8/22 6:30:00 AM ET
    $MGLN
    Hospital/Nursing Management
    Health Care

    Magellan Health Appoints Dr. Caroline Carney as President of Behavioral Health

      Magellan Health, Inc., one of the nation's leaders in behavioral health, today announced it has appointed Caroline Carney, MD, MSc, FAPM, CPHQ, as president of behavioral health for its subsidiary, Magellan Healthcare. In this key leadership role, Dr. Carney will advance Magellan Health's clinical mission and further position the company's significant leadership capabilities in behavioral health, including collaborative and integrated approaches that enhance member experience across the continuum of care. Dr. Carney will also continue in her role as chief medical officer of Magellan Health, leading the development and implementation of innovative, integrated clinical programs for custo

    2/3/22 4:36:00 PM ET
    $MGLN
    Hospital/Nursing Management
    Health Care